-
✅
Jan. 14
-
📣
Jan. 14
-
To be announced
Prof. Dr. Klaus GramannJan. 14
-
Toward Clinical Trial Readiness: Cross-Species EEG Biomarkers in Neurodevelopmental Disorders
Dr. John J. FoxeJan. 14
-
☕
Jan. 14
-
The utility of cognitive ERPs in the management of addictive disorders.
Dr. Salvatore CampanellaJan. 14
-
Hormones as a hidden source of variability: EEG and psychophysiological insights into women's brain health
Prof. Dr. Ramunė GrikšienėJan. 14
-
🥗
Jan. 14
-
EEG Biomarkers, AI and Precision Psychiatry
Prof. Dr. Sebastian OlbrichJan. 14
-
Non-Invasive Remote EEG Monitoring at-home in Epilepsy: The EEG@HOME Study
Dr. Andrea BiondiJan. 14
Event ANT Neuromeeting 2027 - Berlin
starts on
Jan 14, 2027, 8:00:00 AM
(Europe/Berlin)
Peak Alpha Frequency as a Biomarker of Neuroimmune Vulnerability to Chronic Postsurgical Pain
1/14/27, 12:00 PM
-
1/14/27, 12:30 PM
(Europe/Berlin)
(30 minutes)
Dr. Ali Mazaheri
Professor of Translational Neuroscience | Centre for Human Brain Health
at University of Birmingham - School of psychology
Dr. Ali Mazaheri
Professor of Translational Neuroscience | Centre for Human Brain Health
at University of Birmingham - School of psychology
Biography:
Professor Ali Mazaheri is Professor of Translational Neuroscience at the University of Birmingham and a member of the Centre for Human Brain Health. His research focuses on understanding how large-scale brain networks support cognition, health, and disease, using electrophysiological methods including EEG and MEG. Over the past decade, his work has combined cognitive neuroscience with translational and clinical research, developing neurophysiological markers that can predict health outcomes and inform personalised interventions. He leads multidisciplinary studies that integrate neurophysiology, clinical assessment, and biological measures to identify mechanisms that drive differences in patient outcomes. Professor Mazaheri is currently the Chief Investigator of the ACORN Study supported by the Wellcome Leap Untangling Addiction Programme. His work aims to bridge fundamental neuroscience and clinical practice by developing scalable biomarkers that support precision medicine approaches.
Talk Abstract:
Chronic postsurgical pain affects millions of patients worldwide and remains one of the most common long-term complications of surgery. While interventions that reduce perioperative pain signalling can lower the risk of persistent pain, substantial variation exists in individual responses to these preventive approaches. Understanding the mechanisms underlying this heterogeneity is essential for developing precision prevention strategies. In this talk, I will present evidence that peak alpha frequency (PAF), a reproducible and scalable EEG measure, indexes vulnerability to pain chronification. Slower PAF is consistently observed in chronic pain populations and emerging findings suggest it reflects susceptibility to pain-related neural adaptations. I will discuss recent work examining how this neural vulnerability may interact with inflammatory processes, proposing that PAF captures a broader neuroimmune state that predisposes individuals to chronic pain. Together, these findings highlight the potential of EEG-derived signatures to identify at-risk patients and guide personalised approaches to preventing chronic postsurgical pain